Novel Anticoagulants Part 2, unique challenges associated with them in the cardiac surgery patient
Novel Anticoagulants Part 2, unique challenges associated with them in the cardiac surgery patient

Novel Anticoagulants Part 2, unique challenges associated with them in the cardiac surgery patient

  • Faculty: Program director Joseph Basha, CCP
  • Date: November 5th, 2018 10:00 am
  • CEU’s: 1.08 CEUs
  • Price: $16.2
  • Category 1 SDCE CEU
Buy Course
Course Rating:
(0 Reviews)

Latest Reviews

View All

Course description

Novel anticoagulants part II. Joe Basha, CCP explores more about novel anticoagulants and the unique challenges associated with them in the cardiac surgery patient. 

0:00 Novel Anticoagulants - Part 2
0:12 What is DOAC?
1:34 Why DOACs?
2:16 Warfarin vs DOACs
4:27 Properties of Direct Oral Anticoagulants
#perfusion #Anticoagulants #cardiacsurgery
Register and watch for free @ https://library.perfusioneducation.com
Get our Critical Care / Perfusion / ECMO App - https://perfusioneducation.com/perfusion-app/ 
IV Dosage and Rate Calculator - https://mediweb.us/iv-medication-calculator/ 

Meet Your Instructor

Program director Joseph Basha, CCP

Program director Joseph Basha, CCP

Joseph has been a practicing clinical perfusionist for 40 years. Joseph is the CEO of Houston Extracorporeal Technologies and is the program director of The New Orleans Conference

Read Full Bio